MCP.so
登录

Nullary - Negative Results Intelligence For Drug Discovery

@nullary-ai

关于 Nullary - Negative Results Intelligence For Drug Discovery

Nullary is a hosted MCP server that lets AI agents query measured negative results from drug discovery: inactive compounds, failed selectivity panels, terminated clinical trials, failed CRISPR screens, antibody developability failures, and more — each result carrying full provena

基本信息

分类

其他

传输方式

stdio

发布者

nullary-ai

提交者

Valentin Zhigulin

配置

使用下面的配置,将此服务器添加到你的 MCP 客户端。

{
  "mcpServers": {
    "nullary": {
      "url": "https://mcp.nullary.ai/mcp"
    }
  }
}

工具

未检测到工具

工具是从 README 中自动提取的。维护者可以在 ## Tools 标题下列出工具,即可填充这部分内容。

概览

What is Nullary - Negative Results Intelligence For Drug Discovery?

It is an MCP server that provides intelligence on negative results in drug discovery across multiple modalities. It serves researchers seeking failed compounds, terminated trials, inactive screens, and other non-positive outcomes.

How to use Nullary - Negative Results Intelligence For Drug Discovery?

Interact by asking natural language questions about negative results in drug discovery, such as "What's failed against EGFR?" or "Which kinase inhibitors were inactive in ChEMBL?" The README does not specify installation or configuration steps.

Key features of Nullary - Negative Results Intelligence For Drug Discovery

  • Queries failed compounds, trials, and screens by target
  • Supports small molecule, CRISPR, antibody, peptide modalities
  • Includes PROTAC, clinical trial, and other modalities
  • Every response cites its source

Use cases of Nullary - Negative Results Intelligence For Drug Discovery

  • Identify failed compounds against EGFR across modalities
  • Discover inactive kinase inhibitors in the ChEMBL database
  • Explore reasons for terminated Phase 2 oncology trials
  • Find failed CRISPR knockouts for the TP53 gene

FAQ from Nullary - Negative Results Intelligence For Drug Discovery

What types of negative results can I query?

You can query failed compounds, terminated clinical trials, inactive screens, and failed CRISPR knockouts, among other non-positive outcomes.

How are results presented?

Every response includes a citation to its source, providing transparency for the negative results returned.

What modalities are covered?

Supported modalities include small molecule, CRISPR, antibody, peptide, PROTAC, clinical trial, and more.

评论

其他 分类下的更多 MCP 服务器